ATE304603T1 - Induzierendes alphavirengen- expressionssystem - Google Patents

Induzierendes alphavirengen- expressionssystem

Info

Publication number
ATE304603T1
ATE304603T1 AT99909117T AT99909117T ATE304603T1 AT E304603 T1 ATE304603 T1 AT E304603T1 AT 99909117 T AT99909117 T AT 99909117T AT 99909117 T AT99909117 T AT 99909117T AT E304603 T1 ATE304603 T1 AT E304603T1
Authority
AT
Austria
Prior art keywords
rna molecules
gene expression
untranslated
inducing
methods
Prior art date
Application number
AT99909117T
Other languages
English (en)
Inventor
Wolfgang A Renner
Lars Nieba
Marco Boorsma
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Application granted granted Critical
Publication of ATE304603T1 publication Critical patent/ATE304603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
    • C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99909117T 1998-03-27 1999-03-25 Induzierendes alphavirengen- expressionssystem ATE304603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956298P 1998-03-27 1998-03-27
PCT/IB1999/000523 WO1999050432A1 (en) 1998-03-27 1999-03-25 Inducible alphaviral gene expression system

Publications (1)

Publication Number Publication Date
ATE304603T1 true ATE304603T1 (de) 2005-09-15

Family

ID=22151327

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909117T ATE304603T1 (de) 1998-03-27 1999-03-25 Induzierendes alphavirengen- expressionssystem

Country Status (10)

Country Link
US (2) US7005275B2 (de)
EP (1) EP1066395B1 (de)
JP (2) JP2002509729A (de)
AT (1) ATE304603T1 (de)
AU (1) AU757549B2 (de)
CA (1) CA2325564A1 (de)
DE (2) DE1066395T1 (de)
IL (1) IL138615A0 (de)
NZ (1) NZ507195A (de)
WO (1) WO1999050432A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005275B2 (en) * 1998-03-27 2006-02-28 Cytos Biotechnology Ag Inducible alphaviral gene expression system
ES2326101T3 (es) * 1998-07-03 2009-09-30 Dnavec Research Inc. Vector de virus arn cadena (-) para celulas nerviosas.
US7241617B2 (en) * 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
WO2000006205A1 (en) * 1998-07-29 2000-02-10 Invitrogen Corporation Regulated expression of recombinant proteins using rna viruses
AU7938900A (en) * 1999-10-27 2001-05-08 Cytos Biotechnology Ag Method for creating divergent populations of nucleic acid molecules and proteins
AU1647501A (en) 1999-12-10 2001-06-18 Cytos Biotechnology Ag Replicon based activation of endogenous genes
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
ES2330202T5 (es) * 2001-09-06 2014-01-20 Alphavax, Inc. Sistemas vectores basados en replicones de alfavirus
US20060251620A1 (en) * 2002-08-22 2006-11-09 Lidia Ivanova Inducible alphaviral/orip based gene expression system
EP1644508A1 (de) 2003-07-11 2006-04-12 Cytos Biotechnology AG Genexpressionssystem
US20080096274A1 (en) * 2006-10-24 2008-04-24 Guangpu Li Recombinant alphavirus vectors and methods of using same
WO2016209989A1 (en) * 2015-06-26 2016-12-29 The Regents Of The University Of California Methods for rna promoter identification
US9859156B2 (en) * 2015-12-30 2018-01-02 Taiwan Semiconductor Manufacturing Co., Ltd. Interconnection structure with sidewall dielectric protection layer
GB201603374D0 (en) 2016-02-26 2016-04-13 Ucl Business Plc Packaging cell
IL294290A (en) * 2019-12-31 2022-08-01 Elixirgen Therapeutics Inc Transient temperature-based delivery of nucleic acids and proteins to cells and tissues
US20240350605A1 (en) * 2021-09-02 2024-10-24 Elixirgen Therapeutics, Inc. Temperature-controllable, rna immunotherapeutic for cancer
CN113846113B (zh) * 2021-09-09 2022-09-13 臻赫医药(杭州)有限公司 一种有限自我复制mRNA分子系统、制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US5091309A (en) 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
US5217879A (en) * 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5458878A (en) 1990-01-02 1995-10-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
WO1995007994A2 (en) 1993-09-15 1995-03-23 Viagene, Inc. Recombinant alphavirus vectors
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US5532154A (en) 1994-03-21 1996-07-02 Research Development Foundation Mutated alpha virus
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5792462A (en) 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
US6451592B1 (en) 1996-04-05 2002-09-17 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
WO1997038087A2 (en) 1996-04-05 1997-10-16 Chiron Corporation Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
US5811407A (en) * 1997-02-19 1998-09-22 The University Of North Carolina At Chapel Hill System for the in vivo delivery and expression of heterologous genes in the bone marrow
US7005275B2 (en) * 1998-03-27 2006-02-28 Cytos Biotechnology Ag Inducible alphaviral gene expression system

Also Published As

Publication number Publication date
US20060024788A1 (en) 2006-02-02
US7005275B2 (en) 2006-02-28
DE69927249T2 (de) 2006-06-29
DE1066395T1 (de) 2002-04-04
EP1066395B1 (de) 2005-09-14
NZ507195A (en) 2003-07-25
EP1066395A1 (de) 2001-01-10
DE69927249D1 (de) 2005-10-20
JP2002509729A (ja) 2002-04-02
AU2848199A (en) 1999-10-18
US20030053988A1 (en) 2003-03-20
AU757549B2 (en) 2003-02-27
IL138615A0 (en) 2001-10-31
WO1999050432A1 (en) 1999-10-07
CA2325564A1 (en) 1999-10-07
JP2005323620A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
ATE304603T1 (de) Induzierendes alphavirengen- expressionssystem
Zeng et al. Leveraging mRNA sequences and nanoparticles to deliver SARS‐CoV‐2 antigens in vivo
Morrison Site of synthesis of membrane and nonmembrane proteins of vesicular stomatitis virus.
Spirin et al. A continuous cell-free translation system capable of producing polypeptides in high yield
JP6284181B2 (ja) 環状ｒｎａ及びタンパク質の製造方法
Paterson et al. Efficient translation of prokaryotic mRNAs in a eukaryotic cell-free system requires addition of a cap structure
FI932678A7 (fi) Alfaviruksiin perustuvia DNA-ilmentämissysteemejä
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
EP1328653A4 (de) Hochexprimierbare gene
NO20013371L (no) Ekspresjon og eksport av anti-fedmeproteiner som Fc- fusjonsproteiner
DK1187852T3 (da) Ekspression og eksport af interferon-alpha-proteiner som Fc-fusionsproteiner
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
HUP9800329A2 (hu) Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására
CN111094549A (zh) 用于将体细胞重编程的rna复制子
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
HUP0302481A2 (hu) Virulencia gének, fehérjék és alkalmazásuk
Cressey et al. Distinctive features of the respiratory syncytial virus priming loop compared to other non-segmented negative strand RNA viruses
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
Carlson et al. 1-Methylguanosine in place of Y base at position 37 in phenylalanine tRNA is responsible for its shiftiness in retroviral ribosomal frameshifting
US20200362382A1 (en) Methods of preparing modified rna
Amikura et al. Multiple amino acid-excluded genetic codes for protein engineering using multiple sets of tRNA variants
Liu et al. Mutational switching of a yeast tRNA synthetase into a mammalian-like synthetase cytokine
HUP0304053A2 (hu) Új expressziós vektorok és azok alkalmazása
Xue et al. Construction, expression, and characterization of thymosin alpha 1 tandem repeats in Escherichia coli

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1066395

Country of ref document: EP

REN Ceased due to non-payment of the annual fee